HYPERION THERAPEUTICS INC
CIK 0001386858
Revenue (TTM)
$113.97M
+169.1% YoY
Q1 Apr 2015
Net Income (TTM)
−$6.84M
−137.6% YoY
Q1 Apr 2015
EPS Diluted (TTM)
−$0.39
+120.1% YoY
Q1 Apr 2015
Gross Margin
0.2%
Q1 Apr 2015
Operating Margin
-6.1%
Q1 Apr 2015
Net Margin
-6.0%
Q1 Apr 2015
Free Cash Flow (TTM)
−$1.87M
Q1 Apr 2015
Cash
$88.89M
Q1 Apr 2015
Total Debt
—
Q1 Apr 2015
Shares Outstanding
20.98M sh
Q1 Apr 2015